Faculty, Staff and Student Publications
Language
English
Publication Date
6-5-2025
Journal
Nature Communications
DOI
10.1038/s41467-025-60329-9
PMID
40473600
PMCID
PMC12141477
PubMedCentral® Posted Date
6-5-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Metastasis is the main cause of cancer-related deaths, yet the underlying mechanisms remain elusive. Here, using clear cell renal cell carcinoma (ccRCC), a tumor type with frequent lung metastases, we conduct an in vivo genome-wide CRISPR-Cas9 screen and identify HLF as a potent suppressor of lung metastasis. HLF depletion enhances ccRCC cell migration and lung metastasis, whereas HLF overexpression abrogates these effects. In ccRCC patients, HLF expression is reduced at metastatic sites and associates with epigenetic silencing mediated by the SWI/SNF ATPase subunit BRG1. HLF levels negatively correlate with migration potential in collagen. Mechanistically, HLF regulates LPXN expression, modulating the integration of collagen's mechanical cues with the actin cytoskeleton through Paxillin, thereby suppressing cancer cell migration and lung metastasis. Overexpression of HLF or pharmacological inhibition of BRG1 reduces cell invasion across multiple cancer types. Our findings suggest that targeting the BRG1-HLF axis offers a promising therapeutic strategy for combating metastatic cancers.
Keywords
Humans, Lung Neoplasms, Transcription Factors, Animals, DNA Helicases, Cell Line, Tumor, Nuclear Proteins, Mice, Cell Movement, Gene Expression Regulation, Neoplastic, Carcinoma, Renal Cell, Kidney Neoplasms, Female, Gene Silencing, CRISPR-Cas Systems, Renal cell carcinoma, Metastasis, Cell invasion
Published Open-Access
yes
Recommended Citation
Zhou, Jin; Hepperla, Austin; Simon, Jeremy M; et al., "SWI/SNF ATPase Silenced HLF Potentiates Lung Metastasis in Solid Cancers" (2025). Faculty, Staff and Student Publications. 6755.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/6755
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons